CN Patent

CN119371402A — 螺环烯基类或氮杂烯基类化合物及其药物组合物、制备方法和用途

Assigned to Shanghai Meiyue Biotech Development Co Ltd · Expires 2025-01-28 · 1y expired

What this patent protects

本申请涉及一种螺环烯基类或氮杂烯基类化合物及其药物组合物、制备方法和用途，具体而言，提供了一种式(I)所示的螺环烯基类或氮杂烯基类化合物，其可用于制备药物，特别是制备预防和/或治疗补体旁路介导的疾病或病症的药物。式(I)中各基团如说明书中所定义。

USPTO Abstract

本申请涉及一种螺环烯基类或氮杂烯基类化合物及其药物组合物、制备方法和用途，具体而言，提供了一种式(I)所示的螺环烯基类或氮杂烯基类化合物，其可用于制备药物，特别是制备预防和/或治疗补体旁路介导的疾病或病症的药物。式(I)中各基团如说明书中所定义。

Drugs covered by this patent

iptacopan-hydrochloride (IPTACOPAN HYDROCHLORIDE)

Patent Metadata

Patent number: CN119371402A
Jurisdiction: CN
Classification: —
Expires: 2025-01-28
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Meiyue Biotech Development Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.